Leading the way to safer medication
Lopidine
IOPIDINE
Apraclonidine is indicated for:
Irrespective of gender only Adults (18 years old or older)
Apraclonidine is indicated for short-term adjunctive therapy of chronic glaucoma in patients on maximally tolerated medical therapy who require additional intraocular pressure (IOP) reduction to delay laser treatment or glaucoma surgery.
For this indication, the medical literature mentions below treatments (click for details):
Active ingredient Apraclonidine is contraindicated in the following cases:
No gender/age discrimination
No gender/age discrimination
No gender/age discrimination